Stock Analysis

Discover Maider Medical Industry Equipment And 2 Other Stocks Estimated To Be Below Fair Value

Published

In recent weeks, global markets have experienced significant shifts, with U.S. stocks rallying to record highs on optimism about potential economic growth and tax reforms following the election results. Meanwhile, central banks in Europe and Japan are adjusting their policies amidst concerns over inflation and economic stagnation, highlighting a complex global financial landscape. In this environment, identifying undervalued stocks can be crucial for investors seeking opportunities that may offer value relative to their current market price. Understanding what constitutes an undervalued stock involves analyzing factors such as earnings potential, industry position, and broader market trends that could influence future performance.

Top 10 Undervalued Stocks Based On Cash Flows

NameCurrent PriceFair Value (Est)Discount (Est)
goeasy (TSX:GSY)CA$178.25CA$354.0749.7%
NBT Bancorp (NasdaqGS:NBTB)US$50.53US$99.9349.4%
Synovus Financial (NYSE:SNV)US$58.27US$115.2349.4%
JYP Entertainment (KOSDAQ:A035900)₩53700.00₩106763.2749.7%
GRCS (TSE:9250)¥1500.00¥2979.2649.7%
Laboratorio Reig Jofre (BME:RJF)€2.87€5.7450%
Redcentric (AIM:RCN)£1.1725£2.3249.4%
Medios (XTRA:ILM1)€14.76€29.4849.9%
Fine Foods & Pharmaceuticals N.T.M (BIT:FF)€8.24€16.2949.4%
Cellnex Telecom (BME:CLNX)€32.47€64.6849.8%

Click here to see the full list of 895 stocks from our Undervalued Stocks Based On Cash Flows screener.

Let's take a closer look at a couple of our picks from the screened companies.

Maider Medical Industry Equipment (SHSE:688310)

Overview: Maider Medical Industry Equipment Co. Ltd. specializes in the manufacturing of medical equipment and has a market cap of CN¥2.19 billion.

Operations: Revenue segments for Maider Medical Industry Equipment Co. Ltd. are not provided in the available text.

Estimated Discount To Fair Value: 10.8%

Maider Medical Industry Equipment's current trading price of CN¥13.42 is slightly below its estimated fair value of CN¥15.05, indicating a potential undervaluation based on cash flows. Despite recent declines in revenue and net income, with sales dropping to CN¥219.57 million for the nine months ended September 2024 from CN¥329.92 million a year ago, earnings are projected to grow significantly at 86.73% annually, suggesting potential long-term value if growth forecasts materialize.

SHSE:688310 Discounted Cash Flow as at Nov 2024

Shenzhen Breo Technology (SHSE:688793)

Overview: Shenzhen Breo Technology Co., Ltd. focuses on the research and development of portable massage products aimed at alleviating headache swelling, eye fatigue, and shoulder and neck pain, with a market cap of CN¥2.68 billion.

Operations: Revenue Segments (in millions of CN¥):

Estimated Discount To Fair Value: 36.6%

Shenzhen Breo Technology, trading at CN¥32.4, is significantly undervalued based on cash flow analysis with a fair value estimate of CN¥51.14. Despite a decrease in sales to CN¥836.56 million for the nine months ending September 2024 from CN¥941.69 million the previous year, the company turned profitable with net income reaching CN¥13.1 million compared to a loss of CN¥16.33 million last year, highlighting improved financial health and potential investment appeal if profitability continues to grow as forecasted.

SHSE:688793 Discounted Cash Flow as at Nov 2024

Zhejiang Meida Industrial (SZSE:002677)

Overview: Zhejiang Meida Industrial Co., Ltd. focuses on the research, development, manufacture, and sale of household kitchen appliances, particularly integrated stove products in China, with a market cap of CN¥4.85 billion.

Operations: Revenue Segments (in millions of CN¥): Zhejiang Meida Industrial Co., Ltd. generates its revenue from the research, development, manufacture, and sale of household kitchen appliances, with a particular emphasis on integrated stove products in China.

Estimated Discount To Fair Value: 44.2%

Zhejiang Meida Industrial is trading at a significant discount to its fair value of CNY 13.57, with shares currently priced at CNY 7.57, suggesting potential undervaluation based on cash flows. Despite a sharp decline in sales and net income for the nine months ending September 2024 compared to the previous year, earnings are forecasted to grow significantly over the next three years, outpacing market expectations and indicating possible future financial improvement.

SZSE:002677 Discounted Cash Flow as at Nov 2024

Key Takeaways

  • Reveal the 895 hidden gems among our Undervalued Stocks Based On Cash Flows screener with a single click here.
  • Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
  • Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Ready For A Different Approach?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com